Editor’s Note: This article is a reprint. It was originally published March 10, 2019. Boyd Haley, Ph.D., is a chemist specializing in the development of chemicals to chelate toxic metals, both from the environment and the human body. I had the opportunity to interview Haley (above) at the 2018 Academy of Comprehensive Integrative Medicine (ACIM)… Read More »
Those drugs with high risk and no counterbalancing benefit are banned from medical practice and are Schedule I drugs. Conversely, those considered to have the lowest risk would be in Schedule V 5. A drug or chemical can be treated as a Schedule 1 substance for criminal prosecution even if it is not a controlled… Read More »
Health insurer Gateway Health has teamed with mobile app vendor WEconnect Health Management to give Pennsylvania plan members ongoing help with recovery from substance abuse. Gateway is offering an app after inpatient treatment so those patients can join a support network during the first year of recovery. Each year, 23 million Americans seek substance abuse… Read More »
Despite the enormous unmet need for treatment of substance use disorders and the promise of telemedicine to fill some of the gaps in care, the tool remains woefully underused, according to research led by investigators from the Blavatnik Institute at Harvard Medical School. The study, published in the December issue of Health Affairs, analyzed patterns… Read More »